Your browser doesn't support javascript.
loading
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
Ghesquières, Hervé; Larrabee, Beth R; Haioun, Corinne; Link, Brian K; Verney, Aurélie; Slager, Susan L; Ketterer, Nicolas; Ansell, Stephen M; Delarue, Richard; Maurer, Matthew J; Fitoussi, Olivier; Habermann, Thomas M; Peyrade, Fréderic; Dogan, Ahmet; Molina, Thierry J; Novak, Anne J; Tilly, Hervé; Cerhan, James R; Salles, Gilles.
Affiliation
  • Ghesquières H; Department of Hematology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Larrabee BR; Centre de Recherche en Cancérologie de Lyon - INSERM U 1052/CNRS UMR 5286/Centre Léon Bérard, Lyon, France.
  • Haioun C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Link BK; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Verney A; Lymphoid Malignancies Unit, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil, France.
  • Slager SL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
  • Ketterer N; Centre de Recherche en Cancérologie de Lyon - INSERM U 1052/CNRS UMR 5286/Centre Léon Bérard, Lyon, France.
  • Ansell SM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Delarue R; Department of Oncology, University Hospital, Lausanne, Switzerland.
  • Maurer MJ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Fitoussi O; Department of Hematology, Necker Hospital, Paris, France.
  • Habermann TM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Peyrade F; Onco-Hematology, Polyclinique Bordeaux-Nord, Bordeaux, France.
  • Dogan A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Molina TJ; Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Novak AJ; Departments of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tilly H; Department of Pathology, Necker Hospital, Paris, France.
  • Cerhan JR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Salles G; Department of Hematology, Centre Henri Becquerel, Rouen, France.
Hematol Oncol ; 35(4): 447-455, 2017 Dec.
Article in En | MEDLINE | ID: mdl-27282998
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Receptors, IgG / Immunotherapy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: Hematol Oncol Year: 2017 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Receptors, IgG / Immunotherapy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: Hematol Oncol Year: 2017 Document type: Article Affiliation country: Francia